Chesapeake Has a New Chief: Is It Time to Buy?
May 23rd 2013 11:42AM
Updated May 23rd 2013 12:35PM
Anadarko Petroleum executive Robert Lawler has agreed to take the vacant CEO post at Chesapeake Energy , and investors want to know how he will fit into the Chesapeake mold. In some ways, he may be just what the company needs. Working his way up from engineering to senior vice president of international and offshore operations, Lawler is an operations guy at heart that could help Chesapeake start making the most of its massive asset holdings.
Chesapeake is still in the middle of a massive asset sale to pay down debt. Fool.com contributor Tyler Crowe wants to see improvements in operational performance and more clarity with the asset sale before he is ready to make an investment decision. Should you do the same?
With Lawler in charge and the company on its way back to profitability, Chesapeake certainly is in much better shape than it was a year ago, but the market still has this company trading at a big discount. To learn more about Chesapeake and its enormous potential, you're invited to check out The Motley Fool's brand-new premium report on the company. Simply click here now to access your copy.
The article Chesapeake Has a New Chief: Is It Time to Buy? originally appeared on Fool.com.Motley Fool contributor Aimee Duffy has no position in any stocks mentioned. Motley Fool contributor Tyler Crowe has no position in any stocks mentioned. You can follow them both on Twitter @TMFDuffy and TMFDirtyBird. The Motley Fool has the following options: Long Jan 2014 $20 Calls on Chesapeake Energy, Long Jan 2014 $30 Calls on Chesapeake Energy, and Short Jan 2014 $15 Puts on Chesapeake Energy. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.